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In order to know the role of the Xdsg gene in presumptive PGCs (pPGCs) of Xenopus, we attempted to inhibit the translation of Xdsg mRNA in
pPGCs by injecting antisense morpholino oligo (asMO), together with Fluorescein Dextran-Lysine (FDL), into single germ plasm-bearing cells of
32-cell embryos. Among three types of asMOs complementary to different parts of the 5′-untranslated region of Xdsg mRNA tested, only one
asMO, designated as Xdsg-3, inhibited the translation of the mRNA in FDL-labeled pPGCs, resulting in the absence of labeled PGCs in
experimental tadpoles. On the other hand, two other asMOs, Xdsg-1 and -2, did not inhibit the translation, so that a similar number of labeled
PGCs found in FDL-injected but asMO-uninjected control tadpoles were observed in experimental tadpoles derived from asMO-injected embryos.
Surprisingly, use of Xdsg-3 asMO resulted in the disappearance of the protein of Xenopus vasa homolog (Xenopus vasa-like gene 1, XVLG1) from
FDL-labeled pPGCs by inhibiting the translation of XVLG1 mRNA. However, the effect of Xdsg-3 asMO on the translation of Xdsg and XVLG1
mRNAs and PGC formation could be canceled by the coinjection with Xdsg mRNA. Consequently, the Xdsg protein in pPGCs may play an
important role in the formation of PGCs by regulating the production of XVLG1 protein.
© 2006 Elsevier Inc. All rights reserved.Keywords: Antisense morpholino oligo; Xdsg mRNA; Inhibition of PGC formation; Xdsg protein; XVLG1 proteinIntroduction
It is well known that a special cytoplasm or the so-called
germ plasm localized in eggs of Caenorhabditis elegans (C.
elegans), Drosophila melanogaster, zebrafish and Xenopus is
essential for the formation of germ cells (reviewed by
Ikenishi, 1998, Wylie, 1999, Extravour and Akam, 2003). In
these animal species, the precursors of germ cells or
primordial germ cells (PGCs) are derived only from germ
plasm-bearing cells (GPBCs) prior to gastrulation. Accord-
ingly, it has long been believed that the germ plasm contains a
germ cell determinant(s). In Drosophila, the products of a
number of genes, referred to as the posterior group genes
(Ephrussi and Lehmann, 1992), were shown to be indispens-
able for the formation of PGCs by analyses of maternal-effect
mutants, being sterile. Above all, the products of certain genes
such as oskar, vasa and tudor were shown to be localized on⁎ Corresponding author. Fax: +81 6 6605 3161.
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doi:10.1016/j.ydbio.2006.05.025germ plasm-specific polar granules (Hay et al., 1988b;
Bardsley et al., 1993; Lehmann and Rongo, 1993). A
considerable number of gene products were also reported to
be localized on germ plasm-specific, P granules in C. elegans
(Gruidl et al., 1996; Draper et al., 1996; Mello et al., 1996;
Guedes and Priess, 1997) and germinal granules in Xenopus
(Kashikawa et al., 2001; Kloc et al., 2002).
Recently, a novel gene, Xdsg (GenBank accession no.
AF312719, formerly referred to as “Xenopus laevis nuclear
domain-10 protein NDP52”), was immunoscreened using the
no. 48 antibody (Nakazato and Ikenishi, 1989) that reacted with
germinal granules in the germ plasm of Xenopus, (Yamakita et
al., 2004), being similar in ultrastructure to the polar granules in
Drosophila. Xdsg shares homology with genes encoding the
coiled-coil transcriptional coactivator in mammals (Kim et al.,
2003; Kim and Stallcup, 2004; Takahashi et al., 2004) and some
genes of unknown function in Homo sapiens and chick as
described previously (Yamakita et al., 2004). The Xdsg protein
was prominently observed in the cytoplasm of presumptive
PGCs (pPGCs) or descendants of GPBCs of cleaving embryos
Fig. 1. asMOs for Xdsg mRNA (Xdsg-1, -2 and -3 asMOs) employed in the injection experiments. These asMOs are complementary to nucleotide sequences
represented by three different parts (rectangles) of the 5′-UTR of Xdsg mRNA (GenBank accession no. AF312719).
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the gastrula stage onward, probably due to the translation of
zygotic, Xdsg mRNA. This was supported by RT-PCR analysis
that Xdsg mRNA, which was present in oocytes and fertilized
eggs, was not detected in embryos at early blastula (stage 7) but
detected in embryos from late blastula (stage 9) onward.
Immunoelectron microscopy showed that the Xdsg protein was
localized on the germinal granules. However, little is known
about the function of Xdsg, so far.
In the present study, we investigated the role of Xdsg,
especially in germline cells, using antisense morpholino oligo
(asMO). Because the precursor of germline cells or GPBCs of
32-cell embryos (stage 6), which will differentiate into PGCs
at tadpole stage, are easily identified by their location and aTable 1
The effect of antisense morpholino oligo (asMO) for Xdsg mRNA on the formation
Experiment a asMOb No. of embryos
injected
No. of tadpoles normall
developed to stage 46
Series I Xdsg-1 (10 ng) 48 37
Xdsg-2 (10 ng) 41 29
Xdsg-3 (10 ng) 47 36
(5 ng) 44 26 
(1 ng) 44 33
– 26 24
Series II Xdsg-1 (10 ng) 22 12
Xdsg-2 (10 ng) 30 18
Xdsg-3 (10 ng) 25 21
Series III Xdsg-1 (10 ng) 30 22
Xdsg-3 (10 ng) 30 23
Series IV Xdsg-1 (10 ng) 25 14
Xdsg-3 (10 ng) 27 17 
Xdsg-3 (10 ng) +
Xdsg mRNA (12.5 ng)
32 24
a Injection experiments of Series I–IV were carried out on different egg batches, r
embryos were examined in experimental tadpoles.
b Each asMOwas injected, together with FDL or FDL and XdsgmRNA, into single
I. As the percentage of tadpoles without FDL-labeled PGCs in Xdsg-1 or -2 asMO inj
group in Series I, Xdsg-1 or -2 asMO in Series II, Xdsg-1 asMO in Series III, and X
employed as the control.
c Values within parentheses indicate percentage of tadpoles without FDL-labeled P
different from that of Xdsg-1 or -2 asMO-injected one in all series by X2 test (p <
significantly different from that of Xdsg-1 or -2 asMO-injected one. Besides, there
injected and uninjected groups in Series I. In contrast, the percentage of Xdsg-3 asMO
asMO-injected one (p < 0.001).
d The average numbers of these groups are significantly smaller than those of not o
asMO and Xdsg mRNA co-injected groups by Welch's t test (p < 0.001).natural marker or the “dark area” (Ikenishi and Nakazato,
1986). Three types of asMOs which were complementary to
different parts of 5′-untranslated region (5′-UTR) of Xdsg
mRNA were separately injected, together with Fluorescein
Dextran-Lysine (FDL) as a lineage tracer, into single GPBCs
of stage-6 embryos. FDL-labeled PGCs were examined in the
genital ridges of experimental tadpoles derived from the
injected embryos. Only Xdsg-3 asMO caused the inhibition in
translation of Xdsg mRNA in FDL-labeled pPGCs derived
from asMO-injected GPBCs, resulting in the complete absence
of labeled PGCs in the majority of experimental tadpoles.
Moreover, use of Xdsg-3 asMO resulted in the disappearance
of the protein of Xenopus vasa homolog (Xenopus vasa-like
gene 1, XVLG1) (Komiya et al., 1994) from labeled pPGCs.of PGCs
y No. of tadpoles without
FDL-labeled PGCs
No. of tadpoles with
FDL-labeled PGCs
Average no. of
FDL-labeled PGCs ± SD
5 (13.5%) c 32 9.5 ± 8.5
4 (13.8%) 25 6.9 ± 6.7
34 (94%) 2 0.01 ± 0.37 d
17 (65%) 9 1.4 ± 2.6 d
2 (6.1%) 31 8.8 ± 6.0
1 (4.2%) 23 11.0 ± 8.2
0 (0%) 12 11.3 ± 7.3
1 (5.9%) 17 8.4 ± 5.2
18 (85.7%) 3 0.3 ± 0.9 d
0 (0%) 22 12.2 ± 8.0
20 (87%) 3 0.3 ± 0.9 d
1 (7.1%) 13 5.2 ± 4.9
17 (100%) 0 0 d
3 (12.5%) 21 4.0 ± 4.6
espectively. FDL-labeled PGCs derived from asMO-injected GPBCs of stage-6
GPBCs. Only FDL was injected as a control for asMO-injected GPBCs in Series
ected group was not significantly different from that in control, asMO-uninjected
dsg-1 asMO or a mixture of Xdsg-3 asMO and Xdsg mRNA in Series IV were
GCs. The percentage of 10 or 5 ng Xdsg-3 asMO-injected group is significantly
0.001). However, the percentage of 1 ng Xdsg-3 asMO-injected group is not
are no significant differences in the percentages between Xdsg-1 or -2 asMO-
and Xdsg mRNA co-injected group is significantly smaller than that of Xdsg-3
nly the control asMO-uninjected but also Xdsg-1 or -2 asMO-injected or Xdsg-3
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XVLG1 mRNAs and formation of PGCs could be canceled by
the coinjection with Xdsg mRNA. Consequently, a relationship
between Xdsg and XVLG1 proteins in reference to PGC
formation is presented.
Materials and methods
Embryos
Fertilized Xenopus eggs were obtained by injecting gonadotropic hormone
into sexually mature males and females as previously described (Kotani et al.,
1973), and subsequently staged according to Nieuwkoop and Faber (1967).
They were treated with 1.5% cysteine–HCl (Wako pure Chemical Industries
Ltd., Osaka, Japan) in 10% Holtfreter.s solution (60 mM NaCl, 0.67 mM KCl,
0.9 mM CaCl2 and 2.4 mM NaHCO3; pH 8.0) to remove the jelly coat and then
rinsed twice with sterilized distilled water. They were kept in 10% Holtfreter's
solution until the following use.
Injection of asMOs
Three types of Xdsg asMOswere synthesized according to sequences derived
from three different parts of 5′-UTR of Xdsg mRNA (Fig. 1). The sequences of
the asMOs are as follows; Xdsg-1 asMO: 5′-TTCCATATTTACATCTTTCAG-
CAGC-3′, Xdsg-2 asMO: 5′-TCACTGACTGTATATCACTATGAGC-3′ and
Xdsg-3 asMO: 5′-ATGGCATAAACTTGTGCAGAAGGAA-3′. Capped Xdsg
mRNA was synthesized using an Ambion Message Machine kit (Ambion,
Austin, TX, USA). Approximately 4.7 nl of a mixture of each asMO (10 ng
each, except for 1 or 5 ng Xdsg-3 asMO in Series I) and FDL (Molecular
Probes, Inc. Eugene, OR, USA) (at a final concentration of 100 mg/ml) in
Steinberg's saline was used for each injection. Sample solutions were injectedFig. 2. Transverse sections of experimental tadpoles developed from asMO-injected
from the injected GPBC are labeled with FDL (green). The top and bottom represent t
Wolffian duct. Scale bar is 50 μm. (A) A Xdsg-3 asMO-injected tadpole. Two PGCs
in the genital ridges of the tadpole. (A′) A fluorescent micrograph of panel A. A lar
labeled PGCs were not observed in the tadpole. The unlabeled PGCs (arrows) in the ge
injected tadpole. Three PGCs (arrows) are recognized in the genital ridges of the tadp
ridges and a portion of the intestine are clearly stained with FDL. (C) A Xdsg-3 asMO
in the genital ridges. (C′) A fluorescent micrograph of panel C. One of the PGCs (arrow
part of the intestine is composed of the labeled cells, too.into one of, usually, four GPBCs with a ‘dark area’ (Ikenishi and Nakazato,
1986) of 32-cell embryos in a similar manner as previously described (Ikenishi
and Tanaka, 1997). For the controls for asMOs injected in Series I and for
Xdsg-3 asMO in Series IV (Table 1), a sample consisting of only FDL, and a
mixture of Xdsg-3 asMO, Xdsg mRNA (12.5 ng) and FDL were used for the
injection, respectively. The injected embryos with no exudates at the
midblastula stage (stage 8) were transferred into 1/10 Holtfreter solution and
developed to the stages examined.
Examination of labeled PGCs
The experimental embryos in all series were fixed at stage 46, dehydrated
and then embedded in paraplast (Oxford Labware, St. Louis, MO, USA) as
previously described (Heasman et al., 1984). PGCs in the genital ridges were
identified according to the criteria previously adopted (Tanabe and Kotani,
1974), i.e., they were much larger in size than the surrounding somatic cells, and
possessed a lobulated nucleus and still yolk platelets in the cytoplasm. These
features were never shared with somatic cells. The number of FDL-labeled
PGCs in the experimental tadpoles was counted in serial sections (8 μm thick)
using an Olympus microscope model BH2 equipped with epifluorescence optics
(Olympus Kogaku).
Xdsg protein in pPGCs derived from injected GPBCs
In order to monitor the effect of the asMOs on the translation of Xdsg
mRNA in pPGCs, a portion of the injected embryos was fixed at stage 22 in
Series I and stages 12 and 22 in Series III, and embedded in polyester wax
as previously described (Ikenishi and Tanaka, 1997). To examine whether
Xdsg protein was detected in pPGCs derived from Xdsg-3 asMO and Xdsg
mRNA coinjected GPBCs, portions of the asMO-injected and coinjected
embryos in Series IV were fixed at stage 22, and embedded in a similar
manner. Serial polyester wax sections (8 μm thick) of the embryos wereand Xdsg-3 asMO and Xdsg mRNA coinjected stage-6 embryos. Cells derived
he dorsal and ventral sides, respectively. i: intestine, n: notochord, s: somite, Wd:
(arrows) showing characteristics described in Materials and methods are situated
ge number of FDL-labeled cells are recognized in the intestine. However, FDL-
nital ridges are derived from the asMO-uninjected GPBCs. (B) A Xdsg-1 asMO-
ole. (B′) A fluorescent micrograph of panel B. The PGCs (arrows) in the genital
and XdsgmRNA coinjected tadpole. Two PGCs (arrow and arrowhead) are seen
) is labeled with FDL but the other (arrowhead) from uninjected GPBC is not. A
Table 2
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followed by Cy3-labeled, goat anti-rat IgG (1: 100 in dilution; Chemicon
International Inc., Temecula, CA, USA). The fluorescence of Cy3
representing the Xdsg protein was examined in FDL-labeled pPGCs on the
sections by laser confocal microscopy (Olympus Fluoview; Olympus
Kogaku, Tokyo, Japan).
XVLG1 protein in pPGCs derived from injected GPBCs
Portions of the injected embryos at stages 12, 26, 33/34 and 40 in Series III and
at stages 33/34 and 40 in Series IV were fixed and embedded in polyester wax as
described above. Serial sections (8 μm thick) of the embryos were treated with 2L-
13 antibody specific to XVLG1 protein (Komiya et al., 1994), followed by Cy3-
conjugated goat anti-mouse IgG (whole molecule, 1:200 in dilution; Chemicon
International Inc., Temecula, CA, USA). The fluorescence of Cy3 for XVLG1
protein was examined in FDL-labeled and -unlabeled pPGCs from asMO-injected
and uninjected GPBCs, respectively, with the laser confocal microscope.
XVLG1 mRNA in pPGCs of explants from asMO-injected and
uninjected GPBCs
Ten nanograms of Xdsg-1 or -3 asMO was injected into a single GPBC
isolated from stage-6 embryos in Steinberg's saline containing 5% Ficoll, as
previously described (Ikenishi et al., 1984). The asMO-injected and uninjected
GPBCs were left in saline until the control stage-6 embryos developed to stage
8. The explants of injected and uninjected GPBCs were transferred to
Leibovits's L-15 medium and cultured until the control embryos developed to
stages 12, 15 and 23 [those explants from the asMO-injected or uninjected
GPBCs were designated as ‘stage 12’ explants and so on, as previously
described; Ikenishi and Tanaka, 2000].
Whole-mount in situ hybridization was performed for the explants with
antisense or sense probe for XVLG1 mRNA, essentially the same methods as
previously described (Ikenishi and Tanaka, 2000). pPGCs in serial sections
(8 μm thick) of paraffin-embedded explans, which had been colored with the
substrate, were examined and photographed under an Olympus microscope
model BH2 (Olympus Kogaku).Xdsg protein in pPGCs from asMO-injected GPBCs a
Experiment asMO Stage n b No. of embryos
with FDL- and
Cy3-labeled pPGCs
Xdsg protein in
pPGCs from
injected GPBCs
Series I Xdsg-1 22 6 6 (100%) c +
Xdsg-2 22 6 6 (100%) +
Xdsg-3 22 7 0 (0%) −
– 22 6 6 (100%) +
Series III Xdsg-1 12 4 4 (100%) +
22 5 5 (100%) +
Xdsg-3 12 4 4 (100%) ± d
22 5 0 (0%) −
Series IV Xdsg-1 22 5 5 (100%) +
Xdsg-3 22 5 0 (0%) −
Xdsg-3 +
Xdsg mRNA
22 5 4 (80%) +
a Each Xdsg asMO (10 ng) or a mixture of Xdsg-3 asMO and Xdsg mRNA
(12.5 ng) was injected, together with FDL, into single GPBCs of stage-6
embryos. Xdsg protein was examined in FDL-labeled pPGCs of experimental
embryos by immuno-fluorescent microscopy with the antiserum specific to the
protein and Cy3-labeled second antibody.
b Embryos unintentionally selected from each group of Series I, III and IV in
Table 1 were examined, so that they were omitted from the data of the series in
Table 1.
c Values within parentheses indicate percentage of embryos with FDL- and
Cy3-labeled pPGCs or pPGCs having Xdsg protein derived from the injected
GPBCs.
d The fluorescence representing Xdsg protein in pPGCs of this group was
considerably weak as compared with that of Xdsg-1 asMO-injected, uninjected
and Xdsg-3 asMO and Xdsg mRNA co-injected groups.Results
The formation of PGCs from asMO-injected GPBCs in
experimental tadpoles
Each of three types of asMOs was injected, together with
FDL, into one of, usually, four GPBCs with the ‘dark area’
(Ikenishi and Nakazato, 1986) of 32-cell embryos. A complete
absence of FDL-labeled PGCs was observed in 94% of
experimental tadpoles that had developed from 10 ng Xdsg-3
asMO-injected embryos in Series I (Table 1) (Figs. 2A, A′).
Similarly, it was observed in 65 and ca. 6% of experimental
tadpoles that had developed from 5 and 1 ng Xdsg-3 asMO-
injected embryos, respectively. The average number of labeled
PGCs in the 10 or 5 ng Xdsg-3 asMO-injected tadpoles was
significantly smaller than that observed for the 1 ng Xdsg-3
asMO-injected as well as the asMO-uninjected control tadpoles
(p < 0.001). These results may suggest a dose-dependent effect
of the asMO on the percentage and average number. In contrast,
a complete absence was observed in less than 14% of
experimental tadpoles from the 10 ng Xdsg-1 or -2 asMO-
injected embryos and a similar number of labeled PGCs in the
asMO-uninjected control tadpoles was observed in the remain-
ing experimental tadpoles (Table 1; Figs. 2B, B′). Thus, as far as
the injection of 10 ng asMO was concerned, there weresignificant differences in the percentage and average number
between Xdsg-3 and Xdsg-1 or -2 asMO-injected groups
(p < 0.001), but no significant differences were found between
the latter and the uninjected control groups. On the other hand,
FDL-labeled somatic cells derived from injected GPBCs were
mainly observed in endoderm cells, especially in the intestine
(Figs. 2A′, B′) as previously described (Ikenishi et al., 1996),
irrespective of the injected asMO or the dose of Xdsg-3 asMO.
Judging from the percentage and average number, 10 ng asMO
was adopted in the following injection series. Xdsg-1 or -2
asMO andXdsg-1 asMO or a mixture of Xdsg-3 asMO and Xdsg
mRNAwere employed as the control for Xdsg-3 asMO in Series
II and III and in Series IV, respectively. There were significant
differences in the percentage of tadpoles without labeled PGCs
and the average number of labeled PGCs between the Xdsg-3
and Xdsg-1 or -2 asMO-injected groups in Series II and III
(p < 0.001). In Series IV, FDL-labeled PGCs were observed in a
majority of experimental tadpoles from Xdsg-1 asMO-injected
or Xdsg-3 asMO and Xdsg mRNA coinjected embryos (Figs.
2C, C′) while they were never observed in all experimental
tadpoles from Xdsg-3 asMO-injected ones (Table 1). And the
percentage and average number in the coinjected group were not
significantly different from those in the Xdsg-1 asMO-injected
one (p < 0.001) but significantly higher than those in Xdsg-3
asMO-injected group (p < 0.001). These indicate that the
injection of Xdsg-3 asMO results in the failure in the formation
of PGCs from the asMO-injected GPBCs, and that the effect of
the asMO on the formation of PGCs can be canceled by the
coinjection with Xdsg mRNA.
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GPBCs
In principle, pPGCs were identified by the presence of a
granular cytoplasm in the perinuclear region because such a
cytoplasm was found only in pPGCs and never in somatic
endoderm cells of the endoderm cell mass in embryos at stagesFig. 3. pPGCs with or without Xdsg protein in Xdsg asMO-injected embryos. Xdsg
Cells derived from the injected GPBC are labeled with FDL (green). The asMO inject
having a granular cytoplasm in the perinuclear region (arrow) or a pPGC is seen amon
(arrow) is labeled with both FDL and Cy3 but an adjacent somatic endoderm cell w
asMO-injected embryo, showing the fluorescence of Cy3 next to the nucleus which se
region (arrows). They are stained with both FDL (B′) and Cy3 (B″). (C1) Two pP
distinguishable from adjacent somatic endoderm cells. (C1′) Merged image of C1 with
with FDL only. (C2) Merged image of a transverse section of a Xdsg-3 asMO-injected
with Cy3 only (arrowheads) are situated in and next to a cluster of endoderm cells from
respectively. (D) The majority of the endoderm cells are stained with FDL. (D′) Sam
region of three cells (arrows), indicating that they are definitely pPGCs. The nucleu
(arrows) are labeled with both FDL and Cy3.12–40 (Ikenishi and Kotani, 1975). They were further
confirmed to be the cells by the presence of a distinct fluo-
rescence for Xdsg protein in the perinuclear region (Yamakita
et al., 2004), owing to the immunological reaction mentioned
in Materials and methods.
The fluorescence of Cy3 representing Xdsg protein was
detected in the granular cytoplasm adjacent to the nucleus ofprotein is represented by the fluorescence of Cy3 (red), due to immunostaining.
ed and stage examined are labeled on the panels. Scale bar is 50 μm. (A1) A cell
g the endoderm cells. (A1′) Merged image of A1 with FITC and Cy3. The pPGC
ith FDL only. (A2) A pPGC from uninjected GPBCs (arrowhead) in a Xdsg-3
ems to be empty. (B) Two pPGCs having a granular cytoplasm in the perinuclear
GCs having a granular cytoplasm in the perinuclear region (arrows) are easily
FITC and Cy3. The pPGCs (arrows) and the somatic endoderm cells are labeled
embryo with FITC and Cy3. Two pPGCs from asMO-uninjected GPBCs stained
the asMO-injected GPBC. The top and bottom are the dorsal and ventral sides,
e section as in panel D. The fluorescence of Cy3 is prominent in the perinuclear
s seems to be empty. (D″) Merged image of panels D and D′. The three pPGCs
488 K. Ikenishi et al. / Developmental Biology 297 (2006) 483–492FDL-labeled pPGCs in 10 ng Xdsg-3 as well as Xdsg-1 asMO-
injected embryos at stage 12 in Series III (Table 2; Figs. 3A1,
A1′ and B–B″). It was scarcely detected in FDL-labeled pPGCsFig. 4. pPGCs with or without XVLG1 protein in asMO-injected, and Xdsg-3 asMO a
pPGCs is represented by the fluorescence of Cy3 (red), due to immunostaining. Cells d
and the stage examined are labeled on the panels. Scale bar is 50 μm. (A) All endoderm
that the perinuclear cytoplasm of a cell (arrow) is stained with Cy3, it can be conclude
A′. The pPGC (arrow) is stained with both FDL and Cy3. (B) A pPGC having a granul
Same section as in panel B. The endoderm cells in the upper part, including the pPGC (
part of the right-hand corner are unstained. (B″) Same section in panel B. The perinucle
(C) FDL-labeled cell (arrow) is located in the lateral part of the endoderm cell mass in
stained. (C′) Same section as in panel C. The perinuclear region of the cell (arrow) a
indicating that they are definitely pPGCs. (C″) Merged image of panels C and C′. O
(arrowhead) were derived from the asMO-injected and uninjected GPBCs, respective
having a granular cytoplasm in the perinuclear region (arrow) is seen in a central part of
in panel D. The nucleus and its vicinity of the pPGC (arrow) are heavily stainedwith FD
is not stained with Cy3 because of the scant or complete absence of XVLG1 protein f
obviously different in morphological features from the endoderm cells withmany yolk
part of the endoderm cell mass of a transverse section of an embryo. da: dorsal aorta, n
stained with FDL (arrow), is derived from the coinjected GPBC. (E″) Same section
(arrowhead) cells are stained with Cy3. These two cells were defined as pPGCs, owiof the Xdsg-3 asMO-injected embryos at stage 22 in all series
examined (Table 2; Figs. 3C1 and C1′) By contrast, the
fluorescence was distinctly detected throughout the cytoplasmnd XdsgmRNA coinjected embryos. XVLG1 protein in the perinuclear region of
erived from the injected GPBC are labeled with FDL (green). The asMO injected
cells in an embryo are stained with FDL. (A′) Same section as in panel A. Given
d as a pPGC. The nucleus seems to be empty. (A″) Merged image of panels A and
ar cytoplasm in the vicinity of the nucleus (arrow) in the endoderm cell mass. (B′)
arrow) are stainedwith FDL and those derived from an uninjected cell in the lower
ar region of the pPGC (arrow) is weakly stained due to the injection of the asMO.
a transverse section. The nucleus and the perinuclear region of the cell are heavily
nd of another cell (arrowhead) in a more dorsal part is heavily stained with Cy3,
ne pPGC stained with both FDL and Cy3 (arrow) and the other with Cy3 only
ly. The top and bottom are the dorsal and ventral sides, respectively. (D) A pPGC
the endoderm cell mass of a transverse section of an embryo. (D′) Same section as
L. (D″) Same section as in panel D. The perinuclear region of these cells (arrows)
ollowing injection of the asMO. (E) Two cells (arrow and arrowhead), which are
platelets inside at the lower part of this figure, are situated in the uppermost dorsal
: notochord, s: somite. (E′) Same section as in panel E. One of the two cells, being
as in panel E. The perinuclear region of the FDL-labeled (arrow) and unlabeled
ng to the presence of XVLG1 protein in the perinuclear region.
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well as asMO-uninjected, control embryos at that stage (Table
2; Figs. 3D–D″). Thus, the scant or absence of the fluorescence
in FDL-labeled pPGCs of Xdsg-3 asMO-injected embryos
might reflect the inhibition in translation following injection.
However, the fluorescence was clearly detected in FDL-labeled
pPGCs in a majority of Xdsg-3 asMO and Xdsg mRNA
coinjected embryos at stage 22 in Series IV (Table 2). Not
unexpectedly, it was always detected in unlabeled pPGCs from
uninjected GPBCs in asMO-injected and uninjected embryos
(Figs. 3A2 and C2).
XVLG1 protein in pPGCs from asMO-injected and -uninjected
GPBCs
As previously reported on pPGCs of uninjected embryos
(Ikenishi et al., 1996), a fluorescence of Cy3 representing
XVLG1 protein was observed only in the perinuclear region of
pPGCs in Xdsg-1 asMO-injected embryos throughout the
stages examined (Fig. 4), due to the immunological reaction
mentioned in Materials and methods. Above all, the fluores-
cence became apparent in pPGCs from stage 26 onward, so
that it was still evident even in pPGCs with a tiny granular
cytoplasm at stage 40 which were originated by the clonal
divisions of pPGCs with a large granular cytoplasm from the
gastrula stage onward (Dziadek and Dixon, 1975). Accord-
ingly, pPGCs derived from Xdsg-1 asMO-injected GPBCs
were easily identified as cells stained with both FDL and Cy3.
In the case of pPGCs lacking XVLG1 protein from the injected
GPBCs in Xdsg-3 asMO-injected embryos or FDL-labeled but
Cy3-unlabeled pPGCs, identification was done by the presence
of a distinct granular cytoplasm in the perinuclear region, as
described above.
Double-labeled pPGCs with FDL and Cy3 (derived from
injected GPBCs) and FDL-unlabeled but Cy3-labeled pPGCs
(derived from uninjected GPBCs) were detected in the center of
the endoderm of both Xdsg-1 and -3 asMO-injected embryos atTable 3
Proportion of embryos with pPGCs having XVLG1 protein from asMO-injected GP
asMO-injected embryos a
Experiment asMO Stage n b No. of embryos with F
and Cy-3-labeled pPGC
Series III Xdsg-1 12 4 4 (100%) e
Xdsg-3 4 4 (100%)
Xdsg-1 26 9 9 (100%)
Xdsg-3 10 6 (60%)
Xdsg-1 33/34 8 8 (100%)
Xdsg-3 8 0 (0%)
Xdsg-1 40 6 6 (100%)
Xdsg-3 8 0 (0%)
a pPGCs having XVLG1 protein from injected and uninjected GPBCs were examin
2L-13 antibody, followed by Cy3-conjugated second antibody. See Materials and m
b Embryos unintentionally selected from each group in Series III of Table 1 were
c Average number of pPGCs having XVLG1 protein derived from asMO-injected
observed in the average numbers between Xdsg-1and-3 asMO-injected groups at al
d Average number of pPGCs having XVLG1 protein from asMO-uninjected GPBC
between both groups at all stages.
e Values within parentheses indicate percentage of embryos with pPGCs derived fstage 12 in Series III (Figs. 4A–AV and B–BV). No significant
difference was found in the average number of pPGCs of both
types between Xdsg-1 and -3 asMO-injected embryos (Table 3).
However, the fluorescence of Cy3 in FDL-labeled pPGCs in the
latter embryos seemed to be much weaker than that in the
former ones. A considerable number of the double labeled
pPGCs were observed in the central and lateral parts of all of the
Xdsg-1 asMO-injected embryos at stage 26 (Table 3), while a
small number of the double labeled pPGCs were noticed
predominantly in the central part of the endoderm cell mass in 6
out of 10 Xdsg-3 asMO-injected embryos at that stage (Table 3).
The double labeled pPGCs were mostly localized in the lateral
and dorsal parts in Xdsg-1 asMO-injected embryos at stage 33/
34 (Figs. 4C–C″), and in the upper-most dorsal part at stage 40
(Table 3). They were no longer recognized in any part of the
endoderm cell mass in all of the Xdsg-3 asMO-injected
embryos at stages 33/34 and 40. Occasionally, a few FDL-
labeled but Cy3-unlabeled pPGCs, having a distinct granular
cytoplasm in the perinuclear region, were identified in the
central part of the endoderm cell mass in Xdsg-3 asMO-injected
embryos at stages 26 and 33/34 (Figs. 4D–D″). In contrast, the
localization and number of pPGCs from uninjected GPBCs in
Xdsg-3 asMO-injected embryos at stages 26, 33/34 and 40 were
almost similar to those of Xdsg-1 asMO-injected ones at the
corresponding stages (Table 3). This indicates that Xdsg-3
asMO had no effect on the localization and number of pPGCs
derived from uninjected GPBCs in the asMO-injected embryos.
The above-mentioned effect of Xdsg-3 asMO on the
disappearance of XVLG1 protein from pPGCs was also
observed in Xdsg-3 asMO-injected embryos at stages 33/34
and 40 in Series IV. But it was not recognized in Xdsg-3
asMO and Xdsg mRNA coinjected embryos at those stages,
i.e., the double labeled pPGCs were recognized in 3 of 5
coinjected embryos at stage 33/34 and 4 of 5 at stage 40, and
occupied similar locations in the endoderm cell mass to the
counterparts in Xdsg-1 asMO-injected embryos at those
stages (Figs. 4E–E″).BCs and average number of the pPGCs from injected and uninjected GPBCs in
DL-
s
Average no. of FDL- and
Cy3-labeled pPGCs ± SDc
Average no. of FDL-unlabeled
but Cy3-labeled pPGCs ± SDd
6.0 ± 0.8 7.3 ± 1.5
6.8 ± 1.0 5.0 ± 0.8
11.8 ± 4.9 15.1 ± 4.3
2.8 ± 3.0 15.4 ± 5.5
8 ± 2.1 17.4 ± 3.7
0 24.5 ± 8.4
14.2 ± 6.1 31.7 ± 5.5
0 36.4 ± 6.7
ed in each Xdsg-1 or -3 asMO-injected embryo. The protein was detected by the
ethods for details of the injection.
examined, so that these embryos were omitted from the data of Table 1.
GPBC in each group of the experimental embryos. A significant difference is
l stages, except for 12 by t-test (p < 0.001).
s in each group. A significant difference is not detected in the average numbers
rom asMO-injected GPBC.
Fig. 5. XVLG1 mRNA in pPGCs of ‘stage 23’ explants by whole-mount in situ hybridization. A signal for the RNA is clearly observed in cells having a granular
cytoplasm in the perinuclear region (arrows), possibly pPGCs in the explants from Xdsg-3 (A), -1 asMO (B) injected or uninjected (C) GPBC with the antisense probe
for the mRNA. Any signal is not seen in a pPGC (arrow) of the expant from Xdsg-3 (D) or -1 asMO-injected and uninjected GPBC with the sense probe. Scale bar is
20 μm.
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In order to know why XVLG1 protein was eliminated from
the aforementioned pPGCs derived from Xdsg-3 asMO-injected
GPBCs, XVLG1 mRNA in pPGCs was investigated on explants
from asMO-injected and uninjected GPBCs by whole-mount in
situ hybridization. The expression patterns of not only XVLG1
mRNA but also other mRNAs such as GS17, actin andMixer in
‘stages 7’–‘40’ explants were shown to be almost consistent
with those of the mRNAs in whole embryos at the
corresponding stages (Ikenishi and Tanaka, 2000). Besides,
the penetration of RNA probe for XVLG1 mRNA to pPGCs in
explants seemed to be much easier than that to the cells in the
central part of endoderm cell mass of whole embryos in the
previous study (Ikenishi and Tanaka, 2000).
A signal for XVLG1 mRNA was faintly detected, with an
antisense probe for the mRNA, in cells having a granular
cytoplasm in the perinuclear region or pPGCs of all ‘stage 12’
and ‘15’ explants from Xdsg-3 asMO-injected as well as Xdsg-1
asMO-injected and uninjected GPBCs by the hybridization (data
not shown). It became apparent in pPGCs of ‘stage 23’ explants,
irrespective of asMO-injected or uninjected (Figs. 5A–C). The
signal was rarely observed in somatic cells having no such
granular cytoplasm in those explants with the antisense probe.
This is in good agreement with the previous study (Ikenishi and
Tanaka, 2000) that the signal was observed only in a few pPGCs
but never in a large number of somatic endoderm cells, both of
whichwere originated from the same and oneGPBC. In contrast,
any signal was never detected in pPGCs as well as somatic cells
of explants with the sense probe (Fig. 5D).
Discussion
In the injection experiment using 10 ng asMO in the present
study, there were significant differences in the percentage of
tadpoles without FDL-labeled PGCs and the average number of
labeled PGCs between Xdsg-3 asMO-injected group and Xdsg-
1 or -2 asMO-injected group in all series as well as asMO-
uninjected group in Series I (Table 1). Moreover, Xdsg protein
was diffusively and scarcely detected in labeled pPGCs ofXdsg-3 asMO-injected embryos at stages 12 and 22, respec-
tively (Table 2; Figs. 3A1′ and C1′), while it was clearly
observed in the counterparts of Xdsg-1 or-2 asMO-injected and
uninjected ones at those stages (Table 2; Figs. 3B–B″ and
D–D″). These results suggest that Xdsg-3 asMO facilitated
the absence of Xdsg protein in pPGCs derived from asMO-
injected GPBCs, thus resulting in the failure in the differenti-
ation into PGCs. On the other hand, the percentage and average
number in the Xdsg-3 asMO and Xdsg mRNA coinjected group
were significantly higher than those in Xdsg-3 asMO-injected
group in Series IV and Xdsg protein was distinctly detected in
FDL-labeled pPGCs of the coinjected embryos at stage 22
(Table 2). Accordingly, it implies that the labeled pPGCs in the
Xdsg-3 asMO-injected embryos that might be fated to
degenerate were rescued by the injection of Xdsg mRNA.
It is interesting to note that Xdsg-3 asMO caused the
complete absence of XVLG1 protein in pPGCs derived from the
asMO-injected GPBCs (Table 3; Figs. 4D–D″). In addition,
there was a correlation between the XVLG1 and Xdsg proteins
in pPGCs derived from asMO-injected GPBCs, i.e., the
presence and absence of the former were associated with the
presence and absence of the latter, respectively (Figs. 3C1′ and
D′; Figs. 4C′ and D″). Furthermore, in pPGCs of uninjected
embryos the appearance of Xdsg protein considerably preceded
that of XVLG1 protein. That is, the former protein, which was
reported to be prominent in pPGCs at stage 12 (Yamakita et al.,
2004), was already detected in the cells at stage 9 (K. Ikenishi,
unpublished observation) while the latter was first detected at
stage 12 (Ikenishi et al., 1996). Taken together, it is reasonable
to consider that the absence of Xdsg protein in pPGCs derived
from Xdsg-3 asMO-injected GPBCs may be, directly or
indirectly, responsible for the disappearance of XVLG1 protein
from the cells. Assuming that XVLG1 protein or the protein of
Xenopus vasa homolog is also involved in translation like Vasa
protein in Drosophila (Hay et al., 1988a), it is highly probable
that pPGCs lacking XVLG1 protein would not produce protein
(s) which is necessary for the differentiation into PGCs. This
may be consistent with a previous study (Ikenishi and Tanaka,
1997) where PGCs could not be formed from GPBCs into
which the 2L-13 antibody was injected so as to perturb the
function of the XVLG1 protein.
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above, the inhibition in transcription of XVLG1 following the
mid-blastula transition (MBT) (Newport and Kirschner, 1982)
can be considered. Xdsg shares the highest homology with the
genes encoding the coiled-coil transcriptional coactivator in
mammals (Kim et al., 2003; Kim and Stallcup, 2004; Takahashi
et al., 2004). However, XVLG1 mRNA, which was not
detectable in pPGCs of ‘stage 7’ explants of uninjected
GPBCs (Ikenishi and Tanaka, 2000), was always detected in
pPGCs of all ‘stage 10’, ‘15’ and ‘23’ explants from Xdsg-1 or
-3 asMO-injected and uninjected GPBCs by in situ hybridiza-
tion (Figs. 5A–C). Therefore, it is likely that the absence of
XVLG1 protein in pPGCs can be attributed to the inhibition in
translation of XVLG1 mRNA.
In the present study, Xdsg-3 asMO scarcely affected the
differentiation of FDL-labeled somatic cells, mostly endo-
derm cells (Dale and Slack, 1987), from the asMO-injected
GPBC. FDL-labeled somatic cells, together with unlabeled
somatic cells, formed harmonious organs and tissues,
predominantly the intestine in experimental tadpoles from
Xdsg-3 asMO-injected as well as other asMO-injected stage-6
embryos (Fig. 2). By contrast, it severely affected the
differentiation of FDL-labeled pPGCs from the same GPBC
as mentioned above. These remarkable differences may be
related with the paucity and abundance of Xdsg protein in
somatic endoderm cells and pPGCs, respectively (Yamakita et
al., 2004). This was also noticed on the XVLG1protein in the
perturbation experiment with an injection of the 2L-13
antibody, i.e., the somatic descendant of the injected GPBC,
which rarely had the protein, was nearly unaffected by the
antibody, while the pPGCs from the same GPBC, having a
large amount of the protein, were severely affected (Ikenishi
and Tanaka, 1997).
Each of the three asMOs complementary to different
regions of Xdsg mRNA (Fig. 1) was injected into single
GPBCs of stage-6 embryos in the present study. Unlike Xdsg-
1 and -2 asMOs, Xdsg-3 asMO inhibited the appearance of
Xdsg protein in pPGCs derived from asMO-injected GPBCs
(Table 2; Fig. 3). These facts suggested that Xdsg-3 asMO
might succeed in hybridizing to the complementary region of
Xdsg mRNA, thus resulting in the interference of mRNA
translation. This implies that Xdsg mRNA may adopt a three-
dimensional conformation that facilitates hybridization to the
corresponding complementary region of Xdsg mRNA. Alter-
natively, certain protein(s) may be associated with the regions
complementary to Xdsg-1 and -2 asMOs, thus preventing their
hybridization.
Here, we presented the evidence to suggest that Xdsg protein
in pPGCs might play a role in the formation of PGCs by
regulating the production of XVLG1 protein. However, it
remains unclear as to how the translation of XVLG1 mRNA is
regulated in terms of the action of Xdsg protein. Since it was
predicted that Xdsg protein would possess an extended central
coiled-coil domain (Yamakita et al., 2004), a complex of the
protein with other protein(s) may be necessary for the
translation of XVLG1 mRNA. Further investigation will be
needed to resolve this issue.Acknowledgments
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